Pfizer has formed a deal with Antares Pharma, an Ewing, New Jersey-based pharmaceutical company, to develop a combination drug-device rescue pen. This rescue pen will use the Antares QuickShot auto injector and an undisclosed Pfizer drug. 

Pfizer will pay for the development of the product and will be responsible for obtaining US Food and Drug Administration approval of the combination product. The companies intend to enter into a separate supply agreement pursuant to which Antares will provide fully packaged commercial-ready finished product to Pfizer at cost plus margin and Pfizer will then be responsible for commercializing the product in the US, pending FDA approval. Antares will then receive royalties on net sales on the combination product.

Source: Antares Pharma